Sponsored Links

Unigene Laboratories Inc

News and Blogs

Total : 144 View more »

Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty (Business Wire)

biz.yahoo.com | Nov 14, 2008

Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty. - FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE, http:// www.unigene.com), a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs, has been included in the

http://biz.yahoo.com/bw/081114/20081114005056.html?.v=1

WuXi PharmaTech (Cayman) Inc. Q2 2008 Earnings Call Transcript (at Seeking Alpha)

seekingalpha.com | Sep 23, 2008

Good day everyone and welcome to WuXi PharmaTech’s second quarter 2008 results conference call. This call is being recorded. For opening remarks, I would now like to turn the conference over to Dr. Hai Mi, Vice President of Corporate Communications. Dr. Mi, please go ahead, sir. Hai Mi

http://seekingalpha.com/article/96970-wuxi-pharmatech-cayman-inc-q2-2008-earnings-call-transcript?source=yahoo

Unigene

www.pharmaceutical-technology.com | May 7, 2008

Unigene is a biopharmaceutical company that delivers oral and nasal delivered peptide drugs including salmon calcitonin, oral PTH analogs, oral leuprolide and oral desmopressin.

http://www.pharmaceutical-technology.com/contractors/drug_delivery/unigene

Web Sites

Total : 79 View more »

UGNE: Begins Ph I Trial of Oral PTH for Osteoporosis - Zibb.com

www.zibb.com

By Fain Hughes, fhughes@knobias.com Unigene Laboratories, Inc. (UGNE) has initiated a Phase I clinical study in the U.S. with its proprietary formulation of oral PTH for the treatment of osteoporosis. Twenty-four healthy postmenopausal women have been enrolled in the study, which is designed to

http://www.zibb.com/article/4105131/UGNE+Begins+Ph+I+Trial+of+Oral+PTH+for+Osteoporosis

Biopharmaceutical Products in the U.S. and European Markets - Recent Approvals

Influenza Vaccine/CSL [Influenza Virus Vaccine, Trivalent, Types A and B - AFLURIA; Fluvax; Enzira ] - granted on 9/28/07 to CSL Ltd. for prophylaxis against smallpox (in the biodefense stockpile).

http://www.biopharma.com/approvals.html

ASSOC DIR OF CAPITAL PROJECTS THOUSAND OAKS CA AMGEN INC. ASSOC MGR, PROCESS ENGINEERING SEATTLE WA...

www.interphex.com

ASSOC DIR OF CAPITAL PROJECTS THOUSAND OAKS CA AMGEN INC. ASSOC MGR, PROCESS ENGINEERING SEATTLE WA ASTELLAS PHARMA TECHNOLOGIES, EXECUTIVE V.P, SITE OPERATIONS NORMAN OK ASTELLAS PHARMA TECHNOLOGIES, V.P.

http://www.interphex.com/images/100026/2006images/ListforWeb.pdf

Q3 2008 Bowne & Co Earnings Release - After Market Close (CCBN)

biz.yahoo.com

Learn when companies announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by adding it to your calendar.

http://biz.yahoo.com/research/earncal/20081110.html?t=bne

 

[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent

Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public company executives on their company and most recent press releases.

The show is designed to provide viewers with insight into a company's latest news, and its impact on the company's growth.

    Shows air Monday through Friday at:
    http://tv.wallst.net/3-min-press/3-min-press.php

    The following executives were interviewed on today's show:

    1.  Tony Spier, CEO of Wells-Gardner Electronics Corporation (Amex: WGA).
        To view this clip in its entirety, visit:
        http://www.tv.wallst.net/r/3-minute-press/Anthony-Spier/342/1352/
        Ask Tony Spier a question, post a comment on his profile page, and
        join his financial social network today at:
        http://my.wallst.net/Anthony-Spier

    2.  Laurie Latham, CFO and Senior VP of Finance and Administration for
        ViewCast.com, Inc. (OTC Bulletin Board: VCST). To view this clip in
        its entirety, visit:
        http://www.tv.wallst.net/r/3-minute-press/Laurie-Latham/342/1353/
        Ask Laurie Latham a question, post a comment on her profile page, and
        join her financial social network today at:
        http://my.wallst.net/Laurie-Latham

    3.  Steve Eversole, CEO of Kentucky USA Energy, Inc.
        (OTC Bulletin Board: KYUS). To view this clip in its entirety, visit:
        http://www.tv.wallst.net/r/3-minute-press/Steven-Eversole/342/1350/
        Ask Steve Eversole a question, post a comment on his profile page, and
        join his financial social network today at:
        http://my.wallst.net/Steven-Eversole

    4.  Warren Levy, President and CEO for Unigene Laboratories, Inc.
        (OTC Bulletin Board: UGNE). To view this clip in its entirety, visit:
        http://www.tv.wallst.net/r/3-minute-press/Warren-Levy/342/1357/
        Ask Warren Levy a question, post a comment on his profile page, and
        join his financial social network today at:
        http://my.wallst.net/Warren-Levy

    5.  Kenneth Aldrich, CEO of International Stem Cell Corporation
        (OTC Bulletin Board: ISCO). To view this clip in its entirety, visit:
        http://www.tv.wallst.net/r/3-minute-press/Kenneth-Aldrich/342/1351/
        Ask Kenneth Aldrich a question, post a comment on his profile page,
        and join his financial social network today at:
        http://my.wallst.net/Kenneth-Aldrich

    6.  Michael Ansley, President and CEO for Diversified Restaurants Holding,
        Inc. (OTC Bulletin Board: DFRH). To view this clip in its entirety,
        visit:
        http://www.tv.wallst.net/r/3-minute-press/Michael-Ansley/342/1356/
        Ask Michael Ansley a question, post a comment on his profile page, and
        join his financial social network today at:
        http://my.wallst.net/Michael-Ansley

    7.  Colin Hendrick, President and CEO of SmartMetric, Inc.
        (OTC Bulletin Board: SMME). To view this clip in its entirety, visit:
        http://www.tv.wallst.net/r/3-minute-press/Colin-Hendrick/342/1358/
        Ask Colin Hendrick a question, post a comment on his profile page, and
        join his financial social network today at:
        http://my.wallst.net/Colin-Hendrick

    8.  John Maier, CEO of we-R-you Corporation (Pink Sheets: WERU). To view
        this clip in its entirety, visit:
        http://www.tv.wallst.net/r/3-minute-press/John-Maier/342/1354/
        Ask John Maier a question, post a comment on his profile page, and
        join his financial social network today at:
        http://my.wallst.net/John-Maier


About WallStreet Direct, Inc.

WallStreet Direct, Inc. operates Wall St. Network (http://www.wallst.net), a leading source of up-to-the-minute business news, social networking applications, comprehensive financial tools and original multimedia content for the investment community. In addition to WSN, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net), an online hub for business podcasts from well-known business news personalities and publishers, and WallStTV (http://tv.wallst.net), a hub for business and finance video content. We received two hundred eighty dollars from ViewCast.com, Inc. in 2006 for press release dissemination services. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.php.

Contact:

WallStreet Direct, Inc.

800-4-WALLST

SOURCE WallStreet Direct, Inc.; Wells-Gardner Electronics Corporation;

ViewCast.com, Inc.; Kentucky USA Energy, Inc.; Unigene Laboratories,

Inc.; International Stem Cell Corporation; Diversified Restaurants

Holding, Inc.; SmartMetric, Inc.; we-R-you Corporation

http://www.wallst.net

Read more...

Tags: advertising   amex   business   ceo   community   electronics   energy   executive   finance   kentucky   multimedia   networking   online   otc   president   restaurants   video  

Companies: Diversified Restaurant Holdings Inc (DFRH), International Stem Cell Corp (ISCO), Kentucky USA Energy Inc (KYUS), SmartMetric Inc (SMME), Unigene Laboratories, Inc. (UGNE), ViewCast.com, Inc. (VCST), We-R-You Corp (WERU), Wells-Gardner Electronics Corp. (WGA)

Permalink

 

[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent

Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public company executives on their company and most recent press releases.

The show is designed to provide viewers with insight into a company's latest news, and its impact on the company's growth.

    Shows air Monday through Friday at:
    http://tv.wallst.net/3-min-press/3-min-press.php

    The following executives were interviewed on today's show:

1. Thaddeus Dupper, President and CEO for Evolving Systems, Inc. (Nasdaq: EVOL). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/Thaddeus-Dupper/338/1333/

Ask Thaddeus Dupper a question, post a comment on his profile page, and join his financial social network today at:

http://my.wallst.net/Thaddeus-Dupper

2. Nancy Koenig, President for Merge Healthcare Inc. (Nasdaq: MRGE). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/Nancy-Koenig/338/1331/

Ask Nancy Koenig a question, post a comment on her profile page, and join her financial social network today at: http://my.wallst.net/Nancy-Koenig

3. John Wilmers, President and CEO for Ballantyne of Omaha, Inc. (Amex: BTN). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/John-Wilmers/338/1332/

Ask John Wilmers a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/John-Wilmers

4. John Whitney, President for Itronics, Inc. (OTC Bulletin Board: ITRO). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/John-Whitney/338/1325/

Ask John Whitney a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/John-Whitney

5. Dr. Ronald Levy, Executive Vice President for Unigene Laboratories, Inc. (OTC Bulletin Board: UGNE). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/Ronald-Levy/338/1326/

Ask Dr. Ronald Levy a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/Ronald-Levy

6. Roger Dudley, CEO for Fonix Corp. (OTC Bulletin Board: FNIX). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/Roger-Dudley/338/1328/

Ask Roger Dudley a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/Roger-Dudley

7. Douglas Pritt, President and CEO for NavStar Technologies, Inc. (Pink Sheets: NVSR). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/Douglas-Pritt/338/1334/

Ask Douglas Pritt a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/Douglas-Pritt

8. Adam F. Coblin, Chairman and CEO for UDS Group, Inc. (Pink Sheets: UDSG). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/Adam-Coblin/338/1330/

Ask Adam F. Coblin a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/Adam-Coblin

9. Robert Oswald, President for HearAtLast Holdings, Inc. (Pink Sheets: HRAL). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/Robert-Oswald/338/1327/

Ask Robert Oswald a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/Robert-Oswald

10. Douglas Pulver, Senior Managing Director for Bionic Products, Inc. (Pink Sheets: BNPD). To view this clip in its entirety, visit:

http://www.tv.wallst.net/r/3-minute-press/Douglas-Pulver/338/1329/

Ask Douglas Pulver a question, post a comment on his profile page, and join his financial social network today at:

    http://my.wallst.net/Douglas-Pulver


About WallStreet Direct, Inc.

WallStreet Direct, Inc. operates Wall St. Network (http://www.wallst.net), a leading source of up-to-the-minute business news, social networking applications, comprehensive financial tools and original multimedia content for the investment community. In addition to WSN, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net), an online hub for business podcasts from well-known business news personalities and publishers, and WallStTV (http://tv.wallst.net), a hub for business and finance video content. We received fifteen million restricted shares of ITRO from Itronics, Inc. in 2006 for media and advertising services (all shares sold). We received six thousand seven hundred fifty dollars from UDS Group, Inc. in 2006, and an additional eleven thousand seven hundred dollars in 2007, for media and advertising services. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.php.

    (Logo:  http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)

     Contact:
     WallStreet Direct, Inc.
     800-4-WALLST

SOURCE WallStreet Direct, Inc.; Evolving Systems, Inc.; Merge Healthcare Incorporated; Ballantyne of Omaha, Inc.; Itronics, Inc.; Unigene Laboratories, Inc.; Fonix Corporation; NavStar Technologies, Inc.; UDS Group, Inc.; HearAtLast Holdings, Inc.; Bionic Products, Inc.

http://www.wallst.net

Read more...

Tags: advertising   amex   business   ceo   community   executive   finance   healthcare   media   multimedia   nasdaq   networking   online   otc   president   products   technology   video  

Companies: Ballantyne of Omaha, Inc. (BTN), Bionic Products Inc (BNPD), Evolving Systems, Inc. (EVOL), Fonix Corp. (FNIX), Hear AtLast Holdings Inc (HRAL), Itronics Inc. (ITRO), Merge Technologies, Inc. (MRGE), NavStar Technologies Inc (NVSR), UDS Group Inc (UDSG), Unigene Laboratories, Inc. (UGNE)

Permalink

 

Fitness & Health V, Wellness Feature Releases - Zibb.com

The following releases focus on the topic Fitness & Health V, Wellness:

ALL TIME-OFFS ARE IN EASTERN TIME, UNLESS NOTED STORIES MOVED AT 4:35 AM ET ON NOVEMBER 13, 2008.

New Progress on Treatment to Keep You Safe Following Surgery Source: Cortex Pharmaceuticals

Osteoporosis Drugs May Prevent Future Bone Growth Source: Unigene Laboratories, Inc.

TAMPA, Fla.-- AthleteInMe.com Promotes Wellness Online To Reduce Healthcare Costs Source: AthleteInMe.com

CHATSWORTH, Calif.--Natrol Supplements Help Consumers De-Stress, Digest, And Rest During the Hectic Holidays Source: Natrol, Inc.

Of Mice and Men: Award-Winning Oncologist Leads New Advancement in Personalized Medicine Source: Champions Biotechnology

SANTA ANA, Calif.--Survey Reveals Lack of Education by Healthcare Professionals May Be Barrier to Consumers Recognizing Health Benefits of Soy Source: Stremicks Heritage Foods

BRADENTON, Fla.--Gevity Partners With Olympic Athlete to Promote a Healthier Workforce and Reduce Healthcare Costs for Business Owners Source: Gevity

Stem Cells, Reborn Source: International Stem Cell Corporation

The following knowledgeable industry leaders and scholars from Business Wire's ExpertSource database are available to discuss topics relating to Fitness & Health V, Wellness:

Dr. Kirschenbaum is Clinical Director and Chief Program Officer of Wellspring. He is a licensed clinical psychologist in Illinois and California, Professor of Psychiatry & Behavioral Sciences at Northwestern University Medical School, Fellow and Diplomate in Clinical Health Psychology of the American Psychological Association and former president of its Division of Exercise and Sport Psychology. He has served as a consultant to the United States Olympic Committee, the National Basketball Association, the Ladies Professional Golf Association, the Chicago Bears, numerous professional journals, and several major corporations. Dr. Kirschenbaum has provided addresses at many professional conferences worldwide, received numerous grants for research, and published 9 books and 125 journal articles on weight loss, sport psychology, and related topics.

PR Contact: Meredith Schneider

Telephone: (919) 277-1165

mschneider@fwv-us.com

Kathleen Buchanan is CEO of iinnLight Technologies, Inc. and has over 20 years of management experience in the retail sector. She founded iinnLight in 2006 to fulfill her passionate desire to bring the energizing and rejuvenating benefits of light therapy to people proactively pursuing beauty, wellness and vitality. Kathleen has a proven track record for identifying business opportunities and driving revenue growth. Prior to forming iinnLight, she provided management expertise for some of the country's top retail companies. While serving as Senior Vice President for Bloomingdales, she profitably developed a $200 million business for the corporation, distinguishing herself as a key negotiator. Kathleen holds a B.S. Degree in Business from California State Polytechnic University.

PR Contact: Gina Ray

Telephone: 949-370-0941

gray@thepowermarkgroup.com

Registered journalists can submit queries to the ExpertSource staff and/or search for more experts in this and various other topics by going to www.businesswire.com and logging in with your email address and PressPass password. If you are not registered, you may do so at www.businesswire.com. For more information or assistance with ExpertSource, please contact Stacey Frank, ExpertSource Coordinator/Business Wire at 312/223-1037, stacey.frank@businesswire.com.

The following are upcoming Features Package release dates:

November 17 - Food & Beverage III
November 18 - Travel

Questions? Contact Business Wire's Media Relations team at media.relations@businesswire.com or features@businesswire.com.

SOURCE: Business Wire

Business Wire Media Relations Team 
media.relations@businesswire.com 
or 
Business Wire, Washington 
Angela Mendola, 703-243-0400

Read more...

Tags: basketball   biotechnology   business   california   ceo   clinical   consultant   drugs   education   email   exercise   fitness   florida   food   golf   grants   health   healthcare   illinois   media   medical   medicine   men   olympics   online   osteoporosis   pharmaceuticals   president   psychology   research   retail   revenue   surgery   technology   track   travel   university  

Permalink

 

Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty - Zibb.com

Unigene Laboratories, Inc. (OTCBB: UGNE, http:// www.unigene.com), a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs, has been included in the Scrip World Pharmaceutical News "Company League Tables" ranking of the top fifty biotechnology companies in the world ranked by 2007 sales of pharmaceutical products. In the October 31, 2008, edition of the publication, Unigene ranked number thirty-three in the listing, with $12.76 million in sales, representing an increase of over 350% from 2006. Unigene ranked 18th among US-based companies. The executive briefing also singled out Unigene as one of a handful of companies that "reported significantly increased sales for 2007 compared with the previous year."

"We are delighted to be recognized in this fashion by so authoritative a publication as Scrip World Pharmaceutical News," said Dr. Warren Levy, President and CEO of Unigene. "Fortical has now captured more than 59% of U.S. nasal calcitonin prescriptions, further solidifying its position as the most frequently prescribed nasal calcitonin product in the U.S. We continue to be optimistic about the future prospects for Fortical, as well as improved formulations of calcitonin."

About Scrip World Pharmaceutical News

Established in 1976, Scrip World Pharmaceutical News is the leading source of global news in the pharmaceutical industry. Delivering an unrivalled range of pharma market intelligence, Scrip's network of experienced, locally based journalists provide you with a truly international and independent perspective. Scrip World Pharmaceutical News keeps readers abreast of licensing activity, distribution and trade agreements, the actions of companies and associations, and of the policies and practices of governments and their agencies. From drug manufacturers to CROs, biotech companies to regulators, Scrip subscribers know the value of the unbiased, independent pharmaceutical business intelligence that only Scrip provides. For more information, please visit www.scripnews.com.

About Unigene Laboratories, Inc.

Unigene Laboratories, Inc. is a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs. Due to the size of the worldwide osteoporosis market, Unigene is targeting its initial efforts on developing calcitonin and PTH-based therapies. Fortical(R), Unigene's nasal calcitonin product for the treatment of postmenopausal osteoporosis, received FDA approval and was launched in August 2005. Unigene has licensed the U.S. rights for Fortical(R) to Upsher-Smith Laboratories, worldwide rights for its oral PTH technology to GlaxoSmithKline and worldwide rights for its calcitonin manufacturing technology to Novartis. Unigene's patented oral delivery technology has successfully delivered, in preclinical and/or clinical trials, various peptides including calcitonin, PTH and insulin. Unigene's patented manufacturing technology is designed to cost-effectively produce peptides in quantities sufficient to support their worldwide commercialization as oral or nasal therapeutics. For more information about Unigene, call (973) 882-0860 or visit www.unigene.com. For information about Fortical, visit www.fortical.com.

Safe Harbor Statement

Safe Harbor statements under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are based upon Unigene Laboratories, Inc.'s management's current expectations, estimates, beliefs, assumptions, and projections about Unigene's business and industry. Words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "potential," "continue," and variations of these words (or negatives of these words) or similar expressions, are intended to identify forward-looking statements. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various risk factors. These risks and uncertainties include the risks associated with the effect of changing economic conditions, trends in the products markets, variations in Unigene's cash flow, market acceptance risks, technical development risks and other risk factors detailed in Unigene's Securities and Exchange Commission filings.

SOURCE: Unigene Laboratories, Inc.

Unigene Investors: 
The Investor Relations Group 
Erika Moran/Dian Griesel, PhD 
212-825-3210 
or 
Media: 
Janet Vasquez, 212-825-3210

Read more...

Tags: biotechnology   business   business intelligence   ceo   clinical   drugs   fashion   fda   manufacturing   market   osteoporosis   pharmaceuticals   president   products   sales   securities   technology   trade  

Companies: Unigene Laboratories, Inc. (UGNE)

Permalink

 

News from Zibb.com

Explore Related Products

Choose a product :

Close

View all 100 Products ...

Explore in Related Industries

Explore Related Topics

Choose a topic :

Close

View all 100 Topics ...